223 related articles for article (PubMed ID: 15078125)
1. Structural and conformational aspects of the anticoagulant and anti-thrombotic activity of heparin and dermatan sulfate.
Casu B; Guerrini M; Torri G
Curr Pharm Des; 2004; 10(9):939-49. PubMed ID: 15078125
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulant and antithrombin effects of intimatan, a heparin cofactor II agonist.
Buchanan MR; Brister SJ
Thromb Res; 2000 Sep; 99(6):603-12. PubMed ID: 10974347
[TBL] [Abstract][Full Text] [Related]
3. A small fraction of dermatan sulfate with significantly increased anticoagulant activity was selected by interaction with the first complement protein.
Calabrese GC; Alberto MF; Tubio R; Marani MM; Fernández De Recondo ME; Lazzari M; Recondo EF
Thromb Res; 2004; 113(3-4):243-50. PubMed ID: 15140589
[TBL] [Abstract][Full Text] [Related]
4. Active site for heparin cofactor II in low molecular mass dermatan sulfate. Contribution to the antithrombotic activity of fractions with high affinity for heparin cofactor II.
Mascellani G; Liverani L; Parma B; Bergonzini G; Bianchini P
Thromb Res; 1996 Oct; 84(1):21-32. PubMed ID: 8885144
[TBL] [Abstract][Full Text] [Related]
5. Site-directed mutagenesis of arginine 103 and lysine 185 in the proposed glycosaminoglycan-binding site of heparin cofactor II.
Blinder MA; Tollefsen DM
J Biol Chem; 1990 Jan; 265(1):286-91. PubMed ID: 2104620
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a novel dermatan sulfate with high antithrombin activity from ray skin (Raja radula).
Ben Mansour M; Dhahri M; Bertholon I; Ollivier V; Bataille I; Ajzenberg N; Hassine M; Jandrot-Perrus M; Chaubet F; Maaroufi RM
Thromb Res; 2009 Apr; 123(6):887-94. PubMed ID: 19019412
[TBL] [Abstract][Full Text] [Related]
7. Structural features of dermatan sulfates and their relationship to anticoagulant and antithrombotic activities.
Linhardt RJ; al-Hakim A; Liu JA; Hoppensteadt D; Mascellani G; Bianchini P; Fareed J
Biochem Pharmacol; 1991 Sep; 42(8):1609-19. PubMed ID: 1930287
[TBL] [Abstract][Full Text] [Related]
8. Covalent heparin cofactor II-heparin and heparin cofactor II-dermatan sulfate complexes. Characterization of novel anticoagulants.
Monagle P; Berry L; O'Brodovich H; Andrew M; Chan A
J Biol Chem; 1998 Dec; 273(50):33566-71. PubMed ID: 9837939
[TBL] [Abstract][Full Text] [Related]
9. Comparison of heparin- and dermatan sulfate-mediated catalysis of thrombin inactivation by heparin cofactor II.
Liaw PC; Austin RC; Fredenburgh JC; Stafford AR; Weitz JI
J Biol Chem; 1999 Sep; 274(39):27597-604. PubMed ID: 10488098
[TBL] [Abstract][Full Text] [Related]
10. Structure and anticoagulant properties of sulfated glycosaminoglycans from primitive Chordates.
Pavão MS
An Acad Bras Cienc; 2002 Mar; 74(1):105-12. PubMed ID: 11960179
[TBL] [Abstract][Full Text] [Related]
11. Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity.
Maimone MM; Tollefsen DM
J Biol Chem; 1990 Oct; 265(30):18263-71. PubMed ID: 2211700
[TBL] [Abstract][Full Text] [Related]
12. The interaction of glycosaminoglycans with heparin cofactor II: structure and activity of a high-affinity dermatan sulfate hexasaccharide.
Tollefsen DM
Adv Exp Med Biol; 1992; 313():167-76. PubMed ID: 1442260
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
Ofosu FA
Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
[TBL] [Abstract][Full Text] [Related]
14. Activation of heparin cofactor II by dermatan sulfate.
Tollefsen DM; Pestka CA; Monafo WJ
J Biol Chem; 1983 Jun; 258(11):6713-6. PubMed ID: 6687888
[TBL] [Abstract][Full Text] [Related]
15. A unique dermatan sulfate-like glycosaminoglycan from ascidian. Its structure and the effect of its unusual sulfation pattern on anticoagulant activity.
Pavão MS; Mourão PA; Mulloy B; Tollefsen DM
J Biol Chem; 1995 Dec; 270(52):31027-36. PubMed ID: 8537360
[TBL] [Abstract][Full Text] [Related]
16. The preferred pathway of glycosaminoglycan-accelerated inactivation of thrombin by heparin cofactor II.
Verhamme IM; Bock PE; Jackson CM
J Biol Chem; 2004 Mar; 279(11):9785-95. PubMed ID: 14701814
[TBL] [Abstract][Full Text] [Related]
17. Highly sulfated dermatan sulfate from the skin of the ray Raja montagui: anticoagulant activity and mechanism of action.
Ben Mansour M; Dhahri M; Hassine M; Ajzenberg N; Venisse L; Ollivier V; Chaubet F; Jandrot-Perrus M; Maaroufi RM
Comp Biochem Physiol B Biochem Mol Biol; 2010 Jul; 156(3):206-15. PubMed ID: 20363356
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of thrombin inhibition by heparin cofactor II and antithrombin in the presence of the ray (Raja radula) skin dermatan sulfate.
Ben Mansour M; Dhahri M; Vénisse L; Jandrot-Perrus M; Chaubet F; Maaroufi RM
Thromb Res; 2009 Apr; 123(6):902-8. PubMed ID: 19046760
[TBL] [Abstract][Full Text] [Related]
19. Substitution of arginine for Leu444 in the reactive site of heparin cofactor II enhances the rate of thrombin inhibition.
Derechin VM; Blinder MA; Tollefsen DM
J Biol Chem; 1990 Apr; 265(10):5623-8. PubMed ID: 2138609
[TBL] [Abstract][Full Text] [Related]
20. Altered dermatan sulfate structure and reduced heparin cofactor II-stimulating activity of biglycan and decorin from human atherosclerotic plaque.
Shirk RA; Parthasarathy N; San Antonio JD; Church FC; Wagner WD
J Biol Chem; 2000 Jun; 275(24):18085-92. PubMed ID: 10749870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
